Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial

Autor: Harrison, Stephen A, Frias, Juan P, Neff, Guy, Abrams, Gary A, Lucas, K Jean, Sanchez, William, Gogia, Sudhanshu, Sheikh, Muhammed Y, Behling, Cynthia, Bedossa, Pierre, Shao, Lan, Chan, Doreen, Fong, Erica, de Temple, Brittany, Shringarpure, Reshma *, Tillman, Erik J, Rolph, Timothy, Cheng, Andrew, Yale, Kitty
Zdroj: In The Lancet Gastroenterology & Hepatology December 2023 8(12):1080-1093
Databáze: ScienceDirect